Oneness Biotech Co., Ltd. (TPEX:4743)

Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of TWD 33.73 billion. The enterprise value is 28.71 billion.

Market Cap	33.73B
Enterprise Value	28.71B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Oneness Biotech has 478.42 million shares outstanding. The number of shares has increased by 0.31% in one year.

Current Share Class	478.42M
Shares Outstanding	478.42M
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	8.17%
Owned by Institutions (%)	6.42%
Float	304.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	287.48
PB Ratio	3.08
P/TBV Ratio	3.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.47
EV / Sales	244.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-59.52

Financial Position

The company has a current ratio of 37.04, with a Debt / Equity ratio of 0.04.

Current Ratio	37.04
Quick Ratio	35.83
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-92.50

Financial Efficiency

Return on equity (ROE) is -11.42% and return on invested capital (ROIC) is -4.16%.

Return on Equity (ROE)	-11.42%
Return on Assets (ROA)	-4.02%
Return on Invested Capital (ROIC)	-4.16%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	2.73M
Profits Per Employee	-32.62M
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.74

Taxes

In the past 12 months, Oneness Biotech has paid 1.87 million in taxes.

Income Tax	1.87M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.49% in the last 52 weeks. The beta is 0.70, so Oneness Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-33.49%
50-Day Moving Average	64.26
200-Day Moving Average	66.27
Relative Strength Index (RSI)	62.08
Average Volume (20 Days)	2,870,032

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of TWD 117.33 million and -1.40 billion in losses. Loss per share was -2.93.

Revenue	117.33M
Gross Profit	30.86M
Operating Income	-842.48M
Pretax Income	-1.40B
Net Income	-1.40B
EBITDA	-536.52M
EBIT	-842.48M
Loss Per Share	-2.93

Balance Sheet

The company has 5.89 billion in cash and 388.72 million in debt, giving a net cash position of 5.50 billion or 11.49 per share.

Cash & Cash Equivalents	5.89B
Total Debt	388.72M
Net Cash	5.50B
Net Cash Per Share	11.49
Equity (Book Value)	10.97B
Book Value Per Share	21.92
Working Capital	6.05B

Cash Flow

In the last 12 months, operating cash flow was -452.76 million and capital expenditures -29.55 million, giving a free cash flow of -482.32 million.

Operating Cash Flow	-452.76M
Capital Expenditures	-29.55M
Free Cash Flow	-482.32M
FCF Per Share	-1.01

Margins

Gross Margin	26.30%
Operating Margin	-718.06%
Pretax Margin	-1,190.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	-0.31%
Earnings Yield	-4.16%
FCF Yield	-1.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.

Last Split Date	Jul 26, 2024
Split Type	Forward
Split Ratio	1.049967976

Scores

Oneness Biotech has an Altman Z-Score of 26.61 and a Piotroski F-Score of 2.

Altman Z-Score	26.61
Piotroski F-Score	2